Stay updated on Efprezimod Alfa as Immunomodulator in COVID-19 Clinical Trial

Sign up to get notified when there's something new on the Efprezimod Alfa as Immunomodulator in COVID-19 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efprezimod Alfa as Immunomodulator in COVID-19 Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, reflecting a revision from v2.12.2 to v2.13.2.
    Difference
    2%
    Check dated 2024-12-07T10:06:46.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The website has added new features, while several detailed options for data download and participant information have been removed.
    Difference
    3%
    Check dated 2024-11-23T03:47:23.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The website has been updated to version v2.12.2, adding new features for downloading study data in various formats and including detailed participant and study information, while removing the previous version v2.12.1.
    Difference
    3%
    Check dated 2024-11-15T18:49:56.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The website has been updated from version 2.12.0 to 2.12.1.
    Difference
    0.1%
    Check dated 2024-11-01T10:42:53.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential enhancements or features.
    Difference
    0.1%
    Check dated 2024-10-25T00:39:58.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.
    Difference
    0.1%
    Check dated 2024-10-03T04:50:33.000Z thumbnail image

Stay in the know with updates to Efprezimod Alfa as Immunomodulator in COVID-19 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efprezimod Alfa as Immunomodulator in COVID-19 Clinical Trial page.